Skip to main content

Closed

RCKT: Rocket Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-81.8%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage-45.7×

Current ratio6.12×

Rocket Pharmaceuticals, Inc.

RCKTNASDAQ Global Market·USD·Closed

Rocket Pharmaceuticals, Inc.

RCKTNASDAQ·USD·Closed

$3.11

−3.12%

$3.11

−$0.10 (3.12%)

52W Range

20thpctl

Volume

0.52×avg

Mkt Cap

339.59MUSD

P/E

-1.7TTM

Div Yield

–ann

52W Range

20thpctl

Volume

0.52×avg

Market Cap

339.59MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings